Special Issues

Special Issue Title: New insight in Cardiovascular Imaging

· Print Special Issue Flyer

· Deadline for manuscript submissions: 31 December 2022

Special Issue Editor

Guest Editor

Prof. Dr. Zhonghua Sun, PhD, FSCCT

John Curtin Distinguished Professor and Head of Discipline, Medical Radiation Science, Curtin Medical School
Program Lead in Chronic Disease (including in Advanced Imaging), Curtin Health Innovation Research Institute (CHIRI), Faculty of Health Sciences, Curtin University, Australia

Website1 | Website2 | E-Mail

InterestsCardiovascular CT imaging; 3D printing of heart and cardiovascular disease; Diagostic radiation; Radiation dose optimisation; Virtual reality; Augmented reality

Prof. Dr. Yung-Liang Wan, MD, FSCCT

Honorable Professor of Radiology, College of Medicine, Chang Gung University Consultant Radiologist
Department of Medical Imaging and Intervention Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan

Website | E-Mail

InterestsCardiothoracic imaging mainly in coronary CTA; Virtual intravascular endoscopy

Special Issue Information

Dear Colleagues,

We are pleased to announce the special issue “New Insight in Cardiovascular Imaging”. Cardiac imaging modalities play an increasingly important role in the diagnosis and prediction of cardiovascular disease. Advancements in these imaging modalities including echocardiography, CT, MRI and nuclear medicine including hybrid imaging have significantly improved their diagnostic accuracy which is represented in not only the morphology and structure assessment, but also the function assessment of cardiovascular disease. Further, novel imaging tools allow for early detection and quantificaiton of cardiovascular disease, thus improving the patient’s prognostic outcomes. This special issue aims to create a platform for researchers from different disciplines to share their recent research outputs on the use of latest imaging modalities in cardiovascular disease. 

Potential topics include, but not limited to:
? Quantitative assessment of cardiovascular disease using cardiac CT, MRI, echocardiography, SPECT/PET
? New diagnostic modalities including dual-energy CT for detection of extracellular volume (ECV) and shear wave imaging by ultrasound in myocardial stiffness
? Diagnostic efficacy and strategy for coronary artery disease with use of FFRCT including the use of machine learning or deep learning tools
? Tissue characterization by Cardiac MR T1 mapping in cardiovascular disease
? 3D printing in cardiovascular disease
? Virtual reality and augmented reality in cardiovascular disease

Authors are encouraged to discuss with the guest editors to determine the suitability of their intended manuscripts. Before submission authors should carefully read over the journal’s Author guidelines, which are available at Author Instructions via:
We look forward to receiving your excellent work. 

Thank you very much!

Prof. Dr. Zhonghua Sun and Prof. Dr. Yung-Liang Wan

Guest Editors


Manuscript Submission Information

Manuscripts should be submitted online at https://rcm.imrpress.org by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a double-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Reviews in Cardiovascular Medicine is an international peer-reviewed open access quarterly journal published by IMR Press.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is $1950. Submitted papers should be well formatted and use good English.


Cardiovascular disease; Diagnosis; Accuracy; Prevention; Prognosis; Imaging modalities; CT; MRI; PET; Echocardiography; Artificial intelligence

Share This Special Issue


Please wait a minute...
For Selected: Toggle Thumbnails
Changes in left ventricular size, geometry, pump function and left heart pressures during healthy aging
Roger E Peverill
Reviews in Cardiovascular Medicine    2021, 22 (3): 717-729.   DOI: 10.31083/j.rcm2203079
Abstract154)   HTML5)    PDF(pc) (415KB)(76)       Save
There are cross-sectional and longitudinal imaging studies using echocardiography and cardiac magnetic resonance in healthy adult subjects which have demonstrated associations of left ventricular (LV) structure and pump function with age. There are also cross-sectional data regarding the relationships of age with invasively measured left heart chamber pressures. Increasing age is associated with decreases in LV end-diastolic volume (LVEDV), end-systolic volume (LVESV), end-diastolic length (LVEDL), stroke volume (SV) and cardiac output (CO), and increases in relative wall thickness (RWT), LV mass/LVEDV ratio (LVMVR) and ejection fraction (LVEF). Older age is not accompanied by a change in mean left atrial (LA) pressure, but there is both direct and indirect evidence which suggests that LV end-diastolic pressure (LVEDP) increases with age. LVEDV remains lower in older than younger subjects during fluid infusion and the resulting increases in LA pressure. The combination of an increase in LVEF with reductions of both SV and CO demonstrates an age-related increase in divergence between LVEF and LV pump function. A lower LVEDV in older compared to younger subjects can be characterized as an aging-related decrease in LV capacity, with the higher LVEDP in older subjects also indicating a reduction of preload reserve.
Related Articles | Metrics
Role of transthoracic echocardiogram in acute heart failure
Sarah Fitzsimons, Robert N Doughty
Reviews in Cardiovascular Medicine    2021, 22 (3): 741-754.   DOI: 10.31083/j.rcm2203081
Abstract63)   HTML7)    PDF(pc) (554KB)(120)       Save
Acute Heart Failure (AHF) is an increasingly common condition with a poor prognosis. In contrast to CHF where advances in medical therapy and devices has led to significant improvement in morbidity and mortality, the prognosis for AHF has not changed significantly in the last few decades despite efforts to find effective treatment. There are multiple factors that contribute to the high mortality and morbidity of AHF; it can be a diagnostic challenge, determining whether decongestion has been achieved can be difficult, and persisting congestion is commonly present at discharge contributing to early decompensation and rehospitalisation. Transthoracic echocardiogram (TTE) is a unique imaging modality that is non-invasive, can be done at the bedside, in real time during procedures, is affordable and easy to access both in community and inpatient settings. Small hand held 'point of care' scans are increasingly available and being used as an adjunct to improve clinical examination. Consequently, the use of echocardiography to improve outcomes for patients with cardiac disease continues to evolve. In chronic heart failure TTE has established roles in the quantification of HF phenotype, and determination of treatment initiation, escalation and success. However, the role of echocardiogram in AHF is not as well established with society guidelines relying on expert consensus for their recommendations. Use of TTE at all stages of AHF has potential to reduce morbidity and mortality. This review discusses the evidence for use of TTE to improve the diagnosis, prognosis and management of AHF.
Related Articles | Metrics
Unilateral absence of pulmonary artery analysis based on echocardiographic feature
Mingjun Tian, Minjuan Zheng
Reviews in Cardiovascular Medicine    2021, 22 (2): 483-488.   DOI: 10.31083/j.rcm2202055
Abstract107)   HTML13)    PDF(pc) (2222KB)(192)       Save
The unilateral absence of pulmonary artery (UAPA) is a rare congenital cardiovascular malformation, which is asymptomatic and easy to be ignored in early stage. A large number of complications may occur in the later stage. Therefore, early diagnosis and treatment is of great significance. The imaging data of 49 patients with UAPA discovered and confirmed clinically by the echocardiography in our hospital are analyzed. The results show that left pulmonary artery absence is more common (55%) and most of them are associated with other cardiovascular malformations (92%). Atrial septal defect and patent foramen ovale were most common in 56%. In which the absence of isolated pulmonary artery was 8% (4/49), and the absence of right pulmonary artery was 75% (3/4). Especially in the patients with tetralogy of Fallot, 77% (5/9) of them miss the diagnosis of UAPA. This suggests that doctors and sonographers should pay attention to the development of pulmonary artery bifurcation and left and right branches in multi-section, and strengthen the scanning of short axis section of high large artery.
Related Articles | Metrics

Current Issue

  • Volume 22, Issue 3